An experimental vaccine, designed to enlist the body’s own immune system to target cancer cells, has shown promise for treating and preventing certain cancers in mice. The vaccine targets a gene called KRAS that is involved in the development of many types of cancer, including lung, bowel and pancreatic cancer.
The study was conducted at the European Organisation for Research and Treatment of Cancer. The team also found a new way to treat aggressive forms of lung cancers that are able to evade the body’s immune system. Read more . . .